Evidence map›Paper›PMID 34175941›Full record

ArticleBioinformatics (Oxford, England)2021

ELIXIR: providing a sustainable infrastructure for life science data at European scale.

Jennifer Harrow, Rachel Drysdale, Andrew Smith, Susanna Repo, Jerry Lanfear, Niklas Blomberg

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Managing workflow executions with WESkit.Bioinformatics (Oxford, England) · 2026
    Article
  8. The future is FAIR: a community framework for enhanced data management and data sharing.Database : the journal of biological databases and curation · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer HarrowELIXIR Hub, South Building, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.ORCID 0000-0003-0338-3070
Rachel DrysdaleELIXIR Hub, South Building, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.ORCID 0000-0003-3037-0216
Andrew SmithELIXIR Hub, South Building, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
Susanna RepoELIXIR Hub, South Building, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
Jerry LanfearELIXIR Hub, South Building, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
Niklas BlombergELIXIR Hub, South Building, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.ORCID 0000-0003-4155-5910

Funding

European Commission Research Infrastructures Programme of Horizon 2020 ELIXIR-EXCELERATE 676559
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34175941
PMCPMC8388016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.